Chris Folk PhD

Chris is contributing to the innovation, evaluation, and on-boarding of device technologies at Amgen as a member of the Device Strategy team. Drug delivery technologies, such as pumps, microneedles, actuator, and sensor technologies, and novel drug transport technologies are all areas of engagement. Chris first developed commercial and military aircraft engines for General Electric. Following his work at UCLA, Chris moved into medical device development with Microfabrica as the first non-founder employee. Chris next managed the research and development team of catheters at Covidien Neurovascular (formerly ev3). Chris holds a B.S. in Aerospace Engineering from University of Notre Dame, a M.S. in Engineering Mechanics from the University of Cincinnati, and a Ph.D. from UCLA. Chris’ publications include four journal publications, fourteen conference publications, and five issued patents.